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Comments 
A. There are only two groups of liver trans-
plants that are large enough for statistical 
analysis - our own and that of CaIne in 
England. This chapter pertains only to 
our own experience. I. 2 
B. The prognosis for acute hepatitis is so 
difficult to project that a terminal condi-
tion is recognized too late to provide ade-
quate time for locating a suitable donor. 
C. Portal vein patency is imperative in order 
to provide the hepatic homograft with 
necessary hepatotrophic factors. Portosys-
temic shunts are taken down at the time 
of surgery. We prefer to do distal splen- I 
orenal shunts in potential recipients, 
though an end-to-side portacaval shunt 
can readily be taken down also. Hepatic 
artery occlusion is not a contraindicatiot., 
since the donor hepatic artery can be an-
astomosed to the aorta, but this entails 
considerably more dissection. 
D. The Denver experience has been poor in 
malignant disease, and recipients with 
malignancies are now generally avoided. 
Our longest survivor, however, had a 
small incidental hepatoma. Calne has had 
a more favorable experience with malig-
nancies.a 
E. Metabolic diseases treated by hepatic 
transplants are Wilson's disease, alpha,-
antitrypsin deficiency, and tyrosinemia. 
F. Miscellaneous causes for adult hepatic 
transplantation are secondary biliary cir-
rhosis, sclerosing cholangitis, massive he-
patic necrosis, Budd-Chiari syndrome, 
and congenital biliary hypoplasia. 
G. A number of changes were made in Au-
gust 1976 thatresuIted in improved sur-
vival. This latest group is presented sepa-
rately as an indication of th .... sl'r\'ivui 
currently enjoyed. Survival raks heyund 
one year include small number;. Lem an 
disease categories. The longe~I SUeViYvT 
is in good health 9 years' a.·ter trans-
plantation. 
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® 
LIVER TRANSPLANTATION 
FOR CHRONIC LIVER DISEASE 
Qualifying Conditions 
Projected Survival <1 Year. 
Debilitating Encephalopathy 
LIVER TRANSPLANTATION 
I-YEAR SURVIVAL 
1963-1976 
FOLLOWUP TO 1977 
No. of Patients 
Atresia • 13/44 (29%) ________ 
I-YEAR SURVIVAL 
SINCE 1976 
FOLLOWUPTO 1978 ® 
No. of Patients 
./ ~eepatitis ________ 3/10 (30%) ______ ~ 
Children ~ ::::7/12 (58%) 
~g~i ~e:~:hp ~Metabolic Diseases ® ___ ..... 3/4 (75%) -______ -------:::~ 
Neoplasm • 2/3 (67%) 
No Acute Liver Disease 
Under 45 Years of Age 
Patent Portal Vein © 
No Malignancy @ 
® ~ Chronic Hepatitis • 5/17 (30%) _______ 
. /NeoPlasm-------- O/1PE1R%F~ 
Adults ~ Alcoholic Cirrhosis • 1/11 (9%) • 8/18 (44%) 
Age 19to ~
60 Years ~ Primary Biliary Cirrhosis • 0/4 (0%)  
Miscellaneous ® 2/5 (40%) 
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